Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Mar;14(3):239-49.
doi: 10.1016/S1473-3099(13)70250-0. Epub 2013 Dec 10.

Diagnostic point-of-care tests in resource-limited settings

Affiliations
Review

Diagnostic point-of-care tests in resource-limited settings

Paul K Drain et al. Lancet Infect Dis. 2014 Mar.

Abstract

The aim of diagnostic point-of-care testing is to minimise the time to obtain a test result, thereby allowing clinicians and patients to make a quick clinical decision. Because point-of-care tests are used in resource-limited settings, the benefits need to outweigh the costs. To optimise point-of-care testing in resource-limited settings, diagnostic tests need rigorous assessments focused on relevant clinical outcomes and operational costs, which differ from assessments of conventional diagnostic tests. We reviewed published studies on point-of-care testing in resource-limited settings, and found no clearly defined metric for the clinical usefulness of point-of-care testing. Therefore, we propose a framework for the assessment of point-of-care tests, and suggest and define the term test efficacy to describe the ability of a diagnostic test to support a clinical decision within its operational context. We also propose revised criteria for an ideal diagnostic point-of-care test in resource-limited settings. Through systematic assessments, comparisons between centralised testing and novel point-of-care technologies can be more formalised, and health officials can better establish which point-of-care technologies represent valuable additions to their clinical programmes.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

WR is CEO of Daktari Diagnostics, which develops point-of-care test for use in resource-limited settings. All other authors declare no conflicts of interest.

Comment in

  • Point-of-care tests: where is the point?
    Ansumana R, Jacobsen KH, Bockarie MJ, Stenger DA. Ansumana R, et al. Lancet Infect Dis. 2014 Oct;14(10):922-3. doi: 10.1016/S1473-3099(14)70915-6. Lancet Infect Dis. 2014. PMID: 25253405 No abstract available.
  • Point-of-care tests: where is the point?
    Hänscheid T, Rebelo M, Grobusch MP. Hänscheid T, et al. Lancet Infect Dis. 2014 Oct;14(10):922. doi: 10.1016/S1473-3099(14)70914-4. Lancet Infect Dis. 2014. PMID: 25253406 No abstract available.

References

    1. Chin CD, Laksanasopin T, Cheung YK, et al. Microfluidics-based diagnostics of infectious diseases in the developing world. Nature Med. 2011;17:1015–19. - PubMed
    1. Uys PW, Warren R, van Helden PD, et al. Potential of rapid diagnosis for controlling drug-susceptible and drug-resistant tuberculosis in communities where Mycobacterium tuberculosis infections are highly prevalent. J Clin Micro. 2009;47:1484–90. - PMC - PubMed
    1. Mabey D, Peeling RW, Ustianowski A, Perkins MD. Diagnostics for the developing world. Nature Reviews. 2004;2:231–40. - PubMed
    1. Peeling RW, Mabey D. Point-of-care tests for diagnosing infections in the developing world. Clin Microbiol Infect. 2010;16:1062–69. - PubMed
    1. Mabey D, Peeling RW, Perkins MD. Rapid and simple point-of-care diagnostics for STIs. Sex Transm Infect. 2001;7:397–98. - PMC - PubMed

Publication types

MeSH terms